<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03825107</url>
  </required_header>
  <id_info>
    <org_study_id>Dichoptic Video for Amblyopia</org_study_id>
    <nct_id>NCT03825107</nct_id>
  </id_info>
  <brief_title>Dichoptic Video Treatment for Amblyopia</brief_title>
  <official_title>Dichoptic Video Treatment for Amblyopia in Children Age 3-7 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Retina Foundation of the Southwest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Retina Foundation of the Southwest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To determine whether watching contrast-rebalanced dichoptic videos is effective in
           improving visual acuity and reducing interocular suppression in amblyopic children

        2. To compare the amount of visual acuity improvement achieved with the videos to tha
           amount achieved with patching (standard treatment for amblyopia)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contrast-rebalanced binocular iPad tablet games (with fellow eye contrast reduced) have been
      shown to be an effective treatment for amblyopia. However, the games can be challenging for
      some of the youngest children and boring for some of the older children with amblyopia. To
      provide additional treatment options using the same contrast-rebalancing approach, we have
      processed animated videos to allow dichoptic viewing, with full contrast for the amblyopic
      eye and reduced contrast for the fellow eye. Children will be randomly assigned to watch
      dichoptic videos (experimental treatment) or patch 2 hours/day every day(standard-of-care
      amblyopia treatment) for 2 weeks. At the 2-week primary outcome visit, children in the
      patching group will cross over to the videos and return for a secondary outcome visit at 4
      weeks. Families will have the option to continue with the vdeos for up to 8 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 3, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in visual acuity of the amblyopic eye</measure>
    <time_frame>Baseline vs 2 weeks</time_frame>
    <description>HOTV (preferred) or picture chart</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in visual acuity of the amblyopic eye</measure>
    <time_frame>Baseline vs 4 weeks, 6 weeks, and 8 weeks</time_frame>
    <description>HOTV (preferred) or picture charts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Stereoacuity</measure>
    <time_frame>Baseline vs 2, 4, 6, 8 weeks</time_frame>
    <description>Randot Preschool Stereoacuity test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Contrast Balance Index</measure>
    <time_frame>Baseline vs 2, 4, 6, 8 weeks</time_frame>
    <description>Dichoptic Letter chart</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Amblyopia</condition>
  <arm_group>
    <arm_group_label>Patching</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 hours per day 7 days per week patching of the fellow eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dichoptic Videos</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>watching 6 dichoptic videos during each 2 week period</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>patching</intervention_name>
    <description>covering the fellow eye with an eyepatch to force use of the amblyopic eye</description>
    <arm_group_label>Patching</arm_group_label>
    <other_name>occlusion therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dichoptic videos</intervention_name>
    <description>watching contrast-rebalanced dichoptic videos to allow the two eyes to work together</description>
    <arm_group_label>Dichoptic Videos</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  3 to 7 years old

          -  Amblyopic eye visual acuity 20/32-20/125

          -  Fellow eye visual acuity 20/16-25

          -  Interocular visual acuity difference of at least 2 lines

          -  Anisometropia or corrected strabsimus (&lt;5pd)

          -  in glasses at least 8 weeks or no change in visual acuity over two visits

          -  no prior binocular treatment

          -  must be able to see full video screen

        Exclusion Criteria:

          -  prematurity of 8 weeks or more

          -  coexisting ocular or systemic disease

          -  developmental delay

          -  poor ocular alignment (&gt;=5 pd)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eileen E Birch, PhD</last_name>
    <phone>2143633911</phone>
    <phone_ext>113</phone_ext>
    <email>ebirch@retinafoundation.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reed M Jost, MS</last_name>
    <phone>2143633911</phone>
    <phone_ext>113</phone_ext>
    <email>reedjost@retinafoundation.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Eileen E Birch</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eileen E Birch, PhD</last_name>
      <phone>214-363-3911</phone>
      <phone_ext>113</phone_ext>
      <email>ebirch@retinafoundation.org</email>
    </contact>
    <contact_backup>
      <last_name>Reed M Jost, MS</last_name>
      <phone>2143633911</phone>
      <email>reedjost@retinafoundation.org</email>
    </contact_backup>
    <investigator>
      <last_name>Eileen E Birch, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>January 29, 2019</study_first_submitted>
  <study_first_submitted_qc>January 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2019</study_first_posted>
  <last_update_submitted>December 11, 2019</last_update_submitted>
  <last_update_submitted_qc>December 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Retina Foundation of the Southwest</investigator_affiliation>
    <investigator_full_name>Eileen Birch</investigator_full_name>
    <investigator_title>Senior Research Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

